Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Utility of FDG-PET scanning in lymphoma by WHO classification
435
Zitationen
13
Autoren
2003
Jahr
Abstract
We retrospectively evaluated (18)fluoro-2-deoxyglucose positron emission tomography (FDG-PET) scans in 172 patients with lymphoma and correlated results with pathologic diagnosis using the World Health Organization (WHO) classification system. In total, FDG-PET detected disease in at least one site in 161 patients (94%) and failed to detect disease in 11 patients (6%). The most frequent lymphoma diagnoses were diffuse large B-cell lymphoma (LBCL; n = 51), Hodgkin lymphoma (HL; n = 47), follicular lymphoma (FL; n = 42), marginal zone lymphoma (MZL; n = 12), mantle cell lymphoma (MCL; n = 7), and peripheral T-cell lymphoma (PTCL; n = 5). FDG-PET detected disease in 100% of patients with LBCL and MCL and in 98% of patients with HL and FL. In contrast, FDG-PET detected disease in only 67% of MZL and 40% of PTCL. Comparison with bone marrow biopsies showed that FDG-PET was not reliable for detection of bone marrow involvement in any lymphoma subtype.
Ähnliche Arbeiten
Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
2012 · 18.398 Zit.
Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus
1997 · 11.433 Zit.
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
2000 · 9.923 Zit.
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
1977 · 8.400 Zit.
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 · 7.760 Zit.